Treatment of Ewing's sarcoma using an antisense oligodeoxynucleotide to regulate the cell cycle

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 3, 2008, Pages 391-394

  Asami, Satoru ^a   Chin, Motoaki ^a   Shichino, Hiroyuki ^a   Yoshida, Yukihiro ^a   Nemoto, Norimichi ^a   Mugishima, Hideo ^a   Suzuki, Takashi ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Antisense oligodeoxynucleotide; Cell cycle; Ewing's sarcoma family tumor; EWS ets chimeric gene

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; INHIBITOR OF DIFFERENTIATION 2; RNA BINDING PROTEIN EWS; THYMOCYTE ANTIBODY; TRANSCRIPTION FACTOR E1AF; TRANSCRIPTION FACTOR ER81; TRANSCRIPTION FACTOR ERG; TRANSCRIPTION FACTOR FEV; TRANSCRIPTION FACTOR FLI 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE S PHASE; CHROMOSOME TRANSLOCATION; CODON; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; EWING SARCOMA; GENE EXPRESSION; HUMAN; HUMAN CELL; SIGNAL TRANSDUCTION; SMALL CELL SARCOMA;

APOPTOSIS; BONE NEOPLASMS; CELL LINE, TUMOR; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 2; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; ONCOGENE PROTEINS, FUSION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEIN C-FLI-1; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; S PHASE; SARCOMA, EWING'S; TRANSCRIPTION FACTORS;

EID: 41149109010     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.391     Document Type: Article

References (24)

1. Ewing J., Proc. N.Y. Pathol. Soc., 21, 17-24 (1921).
2. Grier H. E., Pediatr. Clin. North Am., 44, 991-1004 (1997).
3. Horowitz M. E., Kinsella T. J., Wexler L. H., Belasco J., Triche T., Tsokos M., Steinberg S. M., McClure L., Longo D. L., Steis R. G., J. Clin. Oncol., 11, 1911-1918 (1993).
4. Stout A. P., Proc. N.Y. Pathol. Soc., 18, 2-12 (1918).
5. Askin F. B., Rosai J., Sibley R. K., Dehner L. P., McAlister W. H., Cancer, 43, 2438-2451 (1979).
6. Zucman J., Delattre O., Desmaze C., Plougastel B., Joubert I., Melot T., Peter M., De Jong P., Rouleau G., Aurias A., Genes Chromosomes Cancer, 5, 271-277 (1992).
7. Zucman J., Melot T., Desmaze C., Ghysdael J., Plougastel B., Peter M., Zucker J. M., Triche T. J., Sheer D., Turc-Carel C., Lenoir G., Aurias A., Thomas G., Delattre O., EMBO J., 12, 4481-4487 (1993).
8. Stephenson C. F., Bridge J. A., Sandberg A. A., Hum. Pathol., 23, 1270-1277 (1992).
9. Urano F., Umezawa A., Yabe H., Hong W., Yoshida K., Fujinaga K., Hata J., Jpn. J. Cancer Res., 89, 703-711 (1998).
10. Ida K., Kobayashi S., Taki T., Hanada R., Bessho F., Yamamori S., Sugimoto T., Ohki M., Hayashi Y., Int. J. Cancer, 63, 500-504 (1995).
11. Prasad D. D., Rao V. N., Reddy E. S., Cancer Res., 52, 5833-5837 (1992).
12. Sjögren H., Meis-Kindblom J., Kindblom L. G., Aman P., Stenman G., Cancer Res., 59, 5064-5067 (1999).
13. Sorensen P. H., Lessnick S. L., Lopez-Terrada D., Liu X. F., Triche T. J., Denny C. T., Nature Genet., 6, 146-151 (1994).
14. Urano F., Umezawa A., Hong W., Kikuchi H., Hata J., Biochem. Biophys. Res. Commun., 219, 608-612 (1996).
15. Jeon I. S., Davis J. N., Braun B. S., Sublett J. E., Roussel M. F., Denny C. T., Shapiro D. N., Oncogene, 10, 1229-1234 (1995).
16. Ichikawa H., Shimizu K., Hayashi Y., Ohki M., Cancer Res., 54, 2865-2868 (1994).
17. Barr F. G., Chatten J., D'Cruz C. M., Wilson A. E., Nauta L. E., Nycum L. M., Biegel J. A., Womer R. B., JAMA, 273, 553-557 (1995).
18. Dunn T., Praissman L., Hagag N., Viola M. V., Cancer Gene Cytogenet., 76, 19-22 (1994).
19. Olsen R. J., Hinrichs S. H., Oncogene, 20, 1756-1764 (2001).
20. Taya Y., Trends Biochem. Sci., 22, 14-17 (1997).
21. Dyson N., Genes Dev., 12, 2245-2262 (1998).
22. Iavarone A., Garg P., Lasorella A., Hsu J., Israel M. A., Genes Dev., 8, 1270-1284 (1994).
23. Lasorella A., Iavarone A., Israel M. A., Mol. Cell. Biol., 16, 2570-2578 (1996).
24. Tanaka K., Iwakuma T., Harimaya K., Sato H., Iwamoto Y., J. Clin. Invest., 99, 239-247 (1997).